Articles On Arc Exploration (ASX:ARX)

The sudden drop in spot gold prices and reintroduction of COVID-19 restrictions in New Zealand have hit the relevant ASX small caps this morning. After 100 days of being virus-free, four COVID-19 cases were detected in the country. New Zeal...

ASX companies continued to raise money in July, with over $4bn shelled out by investors, taking 2020’s total above $30bn. According to Bloomberg, there has been $32.3bn worth of cash raised between January 1 and August 3. This is well ahead...

The Aroa Biosurgery Ltd (ASX: ARX) share price has closed 7.69% higher today after announcing it has secured United States Food and Drug Administration (FDA) clearance for one of its products, ‘Symphony’. In addition, the company received...

Shareholders in biological scaffold maker Aroa Biosurgery (ASX:ARX) got a double treat on Thursday morning after the company received both FDA and European regulator approvals. The Auckland headquartered company makes and sells products bas...

Newly-listed soft tissue regeneration company Aroa Biosurgery (ASX: ARX) has announced that its Symphony and Myriad complex wound healing products have gained clearance from international regulators. Symphony has received approval from the...

Aroa Biosurgery Ltd (ASX: ARX) knocked the lights out on its ASX opening day debut on Friday. The New Zealand-based medical company entered the Australian market on the final day of trading last week. It sold 40 million new shares at an in...

There are many reasons why a company might change its name, from being taken over to hiding a shady past. This year 114 companies have changed their name. Family cyber security provider Wangle Technologies became the much more fitting Famil...

Base metals explorer Cyprium Metals (ASX: CYM) has reported positive results from a drilling campaign at the Hollandaire and Hollandaire West targets within the Cue copper project in WA’s Murchison district. The campaign involved drilling t...